Status: Recruiting
Capstan Medical TMVR Study: FIH
This study is a prospective, multi-center, non-randomized first in human study to evaluate the safety and feasibility of the Capstan Medical TMVR System for intervention in adults with moderate-severe or greater mitral regurgitation who are not surgical candidates.
Participants needed: 10
Trial details
Age: 18+Biological sex: AllType: InterventionalSponsor: Capstan MedicalUpdated: Jul 15, 2026Locations: 3
Eligibility criteria
Age ≥ 18 years at the time of consent. [+4]
LVEF less than 20% [+22]